Evolent Health, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NYSE
Evolent Health's 2026 proxy statement outlines executive compensation adjustments, board refreshment, and a proposal to increase shares under its incentive plan following a challenging 2025.
NYSE
DEFA14A: Evolent Health Sets Date for 2025 Annual Meeting, Outlines Key Proposals for Shareholder Vote
Evolent Health's 2025 Annual Meeting will address director elections, auditor ratification, executive compensation, and an amendment to the incentive compensation plan.
NYSE
Evolent Health's 2025 proxy statement highlights board changes, executive compensation, and a proposal to amend the 2015 Omnibus Incentive Compensation Plan to support future growth.
NYSE
Evolent Health, Inc. has scheduled its 2024 Annual Meeting for June 6, 2024, and is urging shareholders to vote on key proposals, including the election of directors, ratification of the independent auditor, and executive compensation.
NYSE
DEF 14A: Evolent Health's 2024 Proxy Statement: Board Elections, Executive Pay, and Corporate Governance
Evolent Health's 2024 proxy statement outlines key proposals for the annual stockholder meeting, including director elections, auditor ratification, and advisory votes on executive compensation.